Ÿnsect On Track To Enter The Human Food Market With A Positive Assessment From The EFSA
G
etting the provisional green light from the EFSA[1] is a major step forward for the industry.
It should pave the way for future approvals, particularly on human consumption of defatted insect protein, which represents the largest human food market segment in terms of value and volumes, especially in sports and health nutrition.
Ÿnsect has identified these markets as the most promising with YnMeal, one of its defatted ingredients.
Ÿnsect has submitted its Novel Food application (without requesting information protection for five years, so that its data can be used by all within the European sector) demonstrating an allergen profile much lower than using the whole insect.
Ÿnsect will be filing a GRAS request in the USA in the coming months to serve the world's largest market for fitness and sports nutrition.
Ÿnsect has already signed a commercial contract within these markets, demonstrating its leading position in the industry.
On January 13, 2021, the European Food Safety Authority (EFSA) announced a favourable safety assessment of mealworms for human food following the work done by a French IPIFF[2] Food Task Force and its members. The EFSA has concluded that this product is safe for human consumption, under the procedures required by the European Union regarding new food legislation (EU Regulation 2015/2283). This favourable assessment will have to be confirmed by the European Commission's Health Directorate General, which will give the final authorisation for market approval in the European Union.
The mealworm is the first insect to receive a positive safety evaluation for human consumption in the world. This is a recognition that mealworm ingredients are premium products as they are uniquely food grade compared to other insects used only in animal feed.
This breakthrough is a major achievement that rewards the work that has been done for years by the entire European insect industry gathered under the IPIFF umbrella. We hope that this positive assessment will be the first of many explains Antoine Hubert, CEO of Ÿnsect.
✔️ Ÿnsect On Track To Enter The Human Food Market With A Positive Assessment From The EFSA
💕 Found this article helpful? Spread the word and support us!